Andrew Schachat, M.D.
| Appointed: |
2006 |
| Gender: |
Male |
| Languages: |
English |
Ophthalmology
Biographical Sketch
Andrew P. Schachat, MD, is the Vice Chairman for Clinical Affairs at the Cole Eye Institute, Cleveland Clinic, and Director of Clinical Research. He is the former Karl Hagen Professor of Ophthalmology, Vice Chairman for Safety and Quality of the Department of Ophthalmology, and Director of the Ocular Oncology Service, at Johns Hopkins University. He was also Professor of Oncology.
In 2003, Dr. Schachat became Editor-in-Chief of the American Academy of Ophthalmology’s journal, Ophthalmology.
He was born in New York City, attended Princeton University, graduating in 1975, and then medical school at Johns Hopkins University, graduating in 1979. His ophthalmology residency training was at the Wilmer Institute at Johns Hopkins, and his retina and oncology fellowship was at the Wills Eye Hospital in Philadelphia. In 1984, he was Assistant Chief of Service at Wilmer, and he has remained at Wilmer since then.
He was for five years Secretary of Quality of Care for the American Academy of Ophthalmology, and in 2001, President of the Maryland Society of Eye Physicians and Surgeons. He is a former Associate Editor of the Archives of Ophthalmology and a current Editor of two volumes of Ryan’s Retina, 4th Edition, 2006.
Professional Highlights
- Editor, Ophthalmology, the journal of the American Academy of Ophthalmology
- Editor, Medical Retina and Oncology volumes, Ryan's Retina, 4th Ed., Mosby, 2006
- Past Secretary for Quality of Care, American Academy of Ophthalmology
- Past Chair, Preferred Practice Panel Committee, American Academy of Ophthalmology
- Past Chair, Retina Panel, Preferred Practice Panel Committee, AAO
Education & Fellowships
| Medical School: | Johns Hopkins University School of Medicine, Baltimore, MD |
|
| Residency: | Johns Hopkins Hospital, Ophthalmology, Baltimore, MD |
| Fellowship: | Wills Eye Hospital, Retna, Philadelphia, PA |
| Other Education: | (Undergraduate) Princeton University, Princeton, NJ |
Certifications
Specialty Interests
Age-related macular degeneration; clinical trials, diabetic retinopathy.
Innovations & Patents
Has been a principal investigator in most studies that have led to new FDA-approved therapies for age-related macular degeneration.
Awards & Honors
- Former Karl Hagen Professor of Ophthalmology, Johns Hopkins University
- Long record of grants/research funding
- Included in various "best" lists
Princeton University:
- Summa cum laude (chemistry)
- Sigma Xi
- William Foster Memorial Prize
- Merck Index Award
Johns Hopkins University School of Medicine:
- Phi Beta Kappa
- Alpha Omega Alpha
- USPHS NIH Research Grant recipient
Wills Fellowship:
- Heed Ophthalmic Foundation Fellowship, 1982-1983
- Heed-Knapp Fellowship, 1983
Miscellaneous Awards:
- American Academy of Ophthalmology Senior Honor Award, 1998
- American Academy of Ophthalmology Honor Award, 1989
Professional Memberships
- Board of Trustees, American Academy of Ophthalmology
- Macula Society
- Retina Society
- American Society of Retina Specialists
- Association for Research in Vision and Ophthalmology
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/23/2008, Dr. Schachat has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Fiduciary Role. Dr. Schachat serves in a fiduciary capacity, such as an officer or director, for the following companies or other entities:
- American Academy of Ophthalmology
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
